View in EDS

VP5-2024: Eftilagimod alpha (soluble LAG-3) and pembrolizumab in first-line recurrent or metastatic head and neck squamous cell carcinoma: Primary results from Cohort B (CPS less-than 1) of the TACTI-003 study.

Saved in:
Bibliographic Details
Title: VP5-2024: Eftilagimod alpha (soluble LAG-3) and pembrolizumab in first-line recurrent or metastatic head and neck squamous cell carcinoma: Primary results from Cohort B (CPS less-than 1) of the TACTI-003 study.
Authors: Metcalf, R.1 (AUTHOR), Laban, S.2 (AUTHOR), Kristensen, C.A.3 (AUTHOR), Ciuleanu, T-E.4 (AUTHOR), Braña, I.5 (AUTHOR), Soria Rivas, A.6 (AUTHOR), Dieter, S.M.7 (AUTHOR), Bols, A.8 (AUTHOR), Forster, M.D.9 (AUTHOR), Covela, M.R.10 (AUTHOR), Christian, J.11 (AUTHOR), Vogl, F.D.12 (AUTHOR), Mueller, C.12 (AUTHOR), Triebel, F.13 (AUTHOR)
Source: Annals of Oncology. Aug2024, Vol. 35 Issue 8, p754-755. 2p.
Database: Academic Search Ultimate
FullText Text:
  Availability: 0
Header DbId: asn
DbLabel: Academic Search Ultimate
An: 178597501
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: VP5-2024: Eftilagimod alpha (soluble LAG-3) and pembrolizumab in first-line recurrent or metastatic head and neck squamous cell carcinoma: Primary results from Cohort B (CPS less-than 1) of the TACTI-003 study.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AR" term="%22Metcalf%2C+R%2E%22">Metcalf, R.</searchLink><relatesTo>1</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Laban%2C+S%2E%22">Laban, S.</searchLink><relatesTo>2</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Kristensen%2C+C%2EA%2E%22">Kristensen, C.A.</searchLink><relatesTo>3</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Ciuleanu%2C+T-E%2E%22">Ciuleanu, T-E.</searchLink><relatesTo>4</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Braña%2C+I%2E%22">Braña, I.</searchLink><relatesTo>5</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Soria+Rivas%2C+A%2E%22">Soria Rivas, A.</searchLink><relatesTo>6</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Dieter%2C+S%2EM%2E%22">Dieter, S.M.</searchLink><relatesTo>7</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Bols%2C+A%2E%22">Bols, A.</searchLink><relatesTo>8</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Forster%2C+M%2ED%2E%22">Forster, M.D.</searchLink><relatesTo>9</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Covela%2C+M%2ER%2E%22">Covela, M.R.</searchLink><relatesTo>10</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Christian%2C+J%2E%22">Christian, J.</searchLink><relatesTo>11</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Vogl%2C+F%2ED%2E%22">Vogl, F.D.</searchLink><relatesTo>12</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Mueller%2C+C%2E%22">Mueller, C.</searchLink><relatesTo>12</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Triebel%2C+F%2E%22">Triebel, F.</searchLink><relatesTo>13</relatesTo> (AUTHOR)
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22Annals+of+Oncology%22">Annals of Oncology</searchLink>. Aug2024, Vol. 35 Issue 8, p754-755. 2p.
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=asn&AN=178597501
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1016/j.annonc.2024.06.012
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        PageCount: 2
        StartPage: 754
    Titles:
      – TitleFull: VP5-2024: Eftilagimod alpha (soluble LAG-3) and pembrolizumab in first-line recurrent or metastatic head and neck squamous cell carcinoma: Primary results from Cohort B (CPS less-than 1) of the TACTI-003 study.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Metcalf, R.
      – PersonEntity:
          Name:
            NameFull: Laban, S.
      – PersonEntity:
          Name:
            NameFull: Kristensen, C.A.
      – PersonEntity:
          Name:
            NameFull: Ciuleanu, T-E.
      – PersonEntity:
          Name:
            NameFull: Braña, I.
      – PersonEntity:
          Name:
            NameFull: Soria Rivas, A.
      – PersonEntity:
          Name:
            NameFull: Dieter, S.M.
      – PersonEntity:
          Name:
            NameFull: Bols, A.
      – PersonEntity:
          Name:
            NameFull: Forster, M.D.
      – PersonEntity:
          Name:
            NameFull: Covela, M.R.
      – PersonEntity:
          Name:
            NameFull: Christian, J.
      – PersonEntity:
          Name:
            NameFull: Vogl, F.D.
      – PersonEntity:
          Name:
            NameFull: Mueller, C.
      – PersonEntity:
          Name:
            NameFull: Triebel, F.
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 08
              Text: Aug2024
              Type: published
              Y: 2024
          Identifiers:
            – Type: issn-print
              Value: 09237534
          Numbering:
            – Type: volume
              Value: 35
            – Type: issue
              Value: 8
          Titles:
            – TitleFull: Annals of Oncology
              Type: main
ResultId 1